SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-118082
Filing Date
2019-04-25
Accepted
2019-04-25 08:01:04
Documents
15
Period of Report
2019-06-11
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d719156ddef14a.htm DEF 14A 375795
2 GRAPHIC g719156g01k03.jpg GRAPHIC 1242
3 GRAPHIC g719156g10k93.jpg GRAPHIC 5467
4 GRAPHIC g719156g38g88.jpg GRAPHIC 2830
5 GRAPHIC g719156g44o90.jpg GRAPHIC 2807
6 GRAPHIC g719156g52h45.jpg GRAPHIC 43940
7 GRAPHIC g719156g57f19.jpg GRAPHIC 24335
8 GRAPHIC g719156g57x66.jpg GRAPHIC 2790
9 GRAPHIC g719156g68q29.jpg GRAPHIC 50610
10 GRAPHIC g719156g70x82.jpg GRAPHIC 24818
11 GRAPHIC g719156g74u76.jpg GRAPHIC 49298
12 GRAPHIC g719156g80b04.jpg GRAPHIC 1737
13 GRAPHIC g719156g88z98.jpg GRAPHIC 50972
14 GRAPHIC g719156g89i18.jpg GRAPHIC 1775
15 GRAPHIC g719156g98n00.jpg GRAPHIC 1562
  Complete submission text file 0001193125-19-118082.txt   742772
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37813 | Film No.: 19765426
SIC: 2834 Pharmaceutical Preparations